Log in to your IBTimes Account

close
ID
Password

GWP sees positive results from Sativex study



23 November 2009 @ 09:37 am BST

GW Pharmaceuticals has revealed positive results from a clinical study of Sativex in the treatment of cancer pain.

It said the authors of a paper published in the 'Journal of Pain and Symptom Management' conclude that "this study shows that Sativex is efficacious for relief of pain in patients with advanced cancer pain not fully relieved by strong opioids".

Preliminary results from this study have previously been announced by GW.

Story provided by Business Financial Newswire

© 2009 BFNNews.com. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

    Click!
  • Rate this article:

Comments

Post Your Comment

*Name


Charts & market data sponsored by FXCM
advertisement
More Markets
Taihua sales down despite improved H2
China-based pharmaceutical firm Taihua warns that full year sales volumes will be lower than 2008 - despite an improved performance in the second half of...
May Gurney wins £65m Wessex Water contracts
Infrastructure services company May Gurney has won two long-term framework contracts with Wessex Water with a combined value of up to £65m over five yea...
S&U in line, declares second interim divi
Home credit and motor finance provider S&U said results for the period from December 8 to end January were in line with market expectations.Home credit s...

advertisement
 
 
IBTimes © 2010 The IBTimes Company Ltd. All Rights Reserved. Partners